Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 25 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

20%

5 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (2)
Early P 1 (1)
P 1 (10)
P 2 (1)
P 3 (2)
P 4 (3)

Trial Status

Completed11
Active Not Recruiting4
Recruiting4
Not Yet Recruiting2
Enrolling By Invitation2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT06210594Phase 4CompletedPrimary

Staph Intervention for Effective Local Defense

NCT07280598Phase 1Not Yet Recruiting

Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections

NCT01879761Active Not Recruiting

Immune Resolution After Staphylococcus Aureus Bacteremia

NCT06368856Phase 1Active Not Recruiting

Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study

NCT06456424Phase 1Active Not Recruiting

Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection

NCT05117398Phase 3Recruiting

Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus

NCT05899140Phase 4Recruiting

Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial

NCT06495697RecruitingPrimary

Plasma Pharmacological Monitoring of M Penicillins in Methicillin-sensitive Staphylococcus Aureus Bacteremia

NCT04897971Enrolling By InvitationPrimary

Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections

NCT06317688Phase 1Enrolling By Invitation

Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation Mastitis

NCT06319235Phase 1Recruiting

Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®

NCT04210505Phase 4Active Not RecruitingPrimary

Nasal Decolonization of Dialysis Patients Noses

NCT05361135Not ApplicableNot Yet Recruiting

18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia

NCT04803708Phase 1Completed

Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers

NCT04784312Phase 1CompletedPrimary

A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection

NCT04503252CompletedPrimary

Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus

NCT04712123UnknownPrimary

Recurrent S. Aureus Infections in Osteoarticular Infections

NCT03966040Phase 1CompletedPrimary

A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults

NCT01792804Phase 3CompletedPrimary

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options

NCT01375621CompletedPrimary

Livestock Contact and MRSA in Rural Areas

Scroll to load more

Research Network

Activity Timeline